Article Type
Article
Changed
Mon, 12/10/2018 - 16:09
Display Headline
Irritable bowel syndrome: An overview of diagnosis and pharmacologic treatment
Author(s)
Kevin W. Olden, MD
Article PDF
content_70_Suppl_2_SI-3.pdf
Author and Disclosure Information

Kevin W. Olden, MD
Associate Professor of Medicine, Division of Gastroenterology, Mayo Clinic Scottsdale, Scottsdale, AZ

Dr. Olden indicated that he is a consultant for Novartis Pharmaceuticals and GlaxoSmithKline.

Publications
Cleveland Clinic Journal of Medicine
Page Number
S3-S7
Author(s)
Kevin W. Olden, MD
Author(s)
Kevin W. Olden, MD
Author and Disclosure Information

Kevin W. Olden, MD
Associate Professor of Medicine, Division of Gastroenterology, Mayo Clinic Scottsdale, Scottsdale, AZ

Dr. Olden indicated that he is a consultant for Novartis Pharmaceuticals and GlaxoSmithKline.

Author and Disclosure Information

Kevin W. Olden, MD
Associate Professor of Medicine, Division of Gastroenterology, Mayo Clinic Scottsdale, Scottsdale, AZ

Dr. Olden indicated that he is a consultant for Novartis Pharmaceuticals and GlaxoSmithKline.

Article PDF
content_70_Suppl_2_SI-3.pdf
Article PDF
content_70_Suppl_2_SI-3.pdf
Related Articles
Irritable bowel syndrome: New tools and insights for the primary care physician
Page Number
S3-S7
Page Number
S3-S7
Publications
Cleveland Clinic Journal of Medicine
Publications
Cleveland Clinic Journal of Medicine
Article Type
Article
Display Headline
Irritable bowel syndrome: An overview of diagnosis and pharmacologic treatment
Display Headline
Irritable bowel syndrome: An overview of diagnosis and pharmacologic treatment
Citation Override
Cleveland Clinic Journal of Medicine 2003 June;70(suppl 2):S3-S7
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media
Disable zoom
Off